  0 Table of Contents |
  1 Home |
| 2 Examples |
 3 Artifacts Summary |
 3.1 EMA Write API ActivityDefinition |
| 3.2 EMA Write API ActivityDefinition Restrictions |
| 3.3 EMA Write API Marketing Regulated Authorization |
| 3.4 EMA Write API MedicinalProductDefinition |
| 3.5 EMA Write API MedicinalProductDefinition Restrictions |
| 3.6 EMA Write API PackagedProductDefinition |
| 3.7 EMA Write API PackagedProductDefinition |
| 3.8 EMA Write API Regulated Authorization |
| 3.9 EMA Write PMS API Bundle |
| 3.10 EMA Write PMS API Bundle Restrictions |
| 3.11 EMA AdditionalMonitoringIndicator boolean CodeableConcept |
| 3.12 EMA API V2 Identifier |
| 3.13 EMA Application Identifier Number |
| 3.14 EMA ATC Coding |
| 3.15 EMA Coding |
| 3.16 EMA Coding Restrictions |
| 3.17 EMA Duration |
| 3.18 EMA Eudra GMP Number Identifier |
| 3.19 EMA EURD Identifier |
| 3.20 EMA Generic ReferentialTerm CodeableConcept |
| 3.21 EMA Generic ReferentialTerm CodeableConcept restrictions |
| 3.22 EMA Genetically Modified Organisms CodeableConcept |
| 3.23 EMA Identifier Restrictions |
| 3.24 EMA Legal Basis CodeableConcept |
| 3.25 EMA Light ATC CodeableConcept |
| 3.26 EMA Manufacturing Authorization Number Identifier |
| 3.27 EMA Marketing Authorization Identifier |
| 3.28 EMA Master File Identifier |
| 3.29 EMA Master File Identifier Restrictions |
| 3.30 EMA Master Identifier |
| 3.31 EMA MP Identifier |
| 3.32 EMA Orphan Designation Number Identifier |
| 3.33 EMA PC Identifier |
| 3.34 EMA Period |
| 3.35 EMA Period restrictions |
| 3.36 EMA Pharmacovigilance Qualified Person Type CodeableConcept |
| 3.37 EMA Pharmacovigilance Qualified Person Type CodeableConcept |
| 3.38 EMA Product Category CodeableConcept |
| 3.39 EMA Quantity |
| 3.40 EMA Ratio |
| 3.41 EMA Ratio |
| 3.42 EMA Reference Restrictions |
| 3.43 EMA xEVMPD Identifier |
| 3.44 EMA XEVMPD Product CodeableConcept |
| 3.45 The MPD Name Part Type Coding |
| 3.46 Authorised Dose Form |
| 3.47 Code System Name |
| 3.48 Date of Update extension |
| 3.49 Language |
| 3.50 MedicinalProductDefiniton - MasterFile |
| 3.51 Reason |
| 3.52 Regulated Authorization - Date of First Authorisation |
| 3.53 Regulated Authorization - International Birth Date |
| 3.54 Regulated Authorization - Paediatric - Reference Country |
| 3.55 Risk of Supply Shortage |
| 3.56 Risk of Supply Shortage Comment |
| 3.57 String Repeat |
| 3.58 Submission Date extension |
| 3.59 Term Version |
| 3.60 The ATC Pending Extension |
| 3.61 The Comparator Extension |
| 3.62 The Complies with directive Extension |
| 3.63 The Ingredient Annex 5.10 Extension |
| 3.64 The Ingredient Annex 5.11 Extension |
| 3.65 The Ingredient Annex 5.20 Extension |
| 3.66 The Ingredient Annex 5.23 Extension |
| 3.67 The Ingredient Documentation Extension |
| 3.68 The Ingredient's Origin of Substance Extension |
| 3.69 The Intended Effect Extension |
| 3.70 The Operation Extension |
| 3.71 The Package Shelf Life Duration Extension |
| 3.72 Additional Monitoring Indicator |
| 3.73 Application Submission Type |
| 3.74 Authorised Dose Form |
| 3.75 Combined Pharmaceutical Dose Form |
| 3.76 Country |
| 3.77 Data Classification |
| 3.78 Documentation |
| 3.79 Domain |
| 3.80 Genetically Modified Organism |
| 3.81 Ingredient Role |
| 3.82 Language |
| 3.83 Legal Status of Supply |
| 3.84 Manufacturing Activity |
| 3.85 Marketing and Manufacturing types |
| 3.86 Marketing Status |
| 3.87 Marketing Status Reason |
| 3.88 Master File Identifier Type |
| 3.89 Master File Type |
| 3.90 Master File Type + DocumentType |
| 3.91 Material |
| 3.92 Medical Dictionary For Regulatory Activities |
| 3.93 Medicinal Product Name Part Type |
| 3.94 Medicinal Product Type |
| 3.95 Medicine Profile |
| 3.96 Packaging |
| 3.97 Paediatric Use Indicator |
| 3.98 Pharmaceutical Dose Form |
| 3.99 Product Category |
| 3.100 Product Cross Reference Type |
| 3.101 Promotion |
| 3.102 Quantity Operator |
| 3.103 Record Status |
| 3.104 Regulatory Authorization Registration Procedure |
| 3.105 Regulatory Entitlement Status |
| 3.106 Regulatory Entitlement Type |
| 3.107 Shelf Life Type |
| 3.108 Special Precautions For Storage |
| 3.109 Substance Origin |
| 3.110 Supply |
| 3.111 Target Species |
| 3.112 Unit of Measurement |
| 3.113 Units of Presentation |
| 3.114 XEVMPD medicinal product type |
| 3.115 XEVMPD medicinal product type |
| 3.116 Additional Monitoring Indicator |
| 3.117 Application Submission Type |
| 3.118 Combination Package |
| 3.119 Combined Pharmaceutical Dose Form |
| 3.120 Combined Term |
| 3.121 Contact Type |
| 3.122 Country |
| 3.123 Data Classification |
| 3.124 Document Type |
| 3.125 Documentation |
| 3.126 Domain |
| 3.127 Genetically Modified Organism |
| 3.128 Ingredient Role |
| 3.129 Language |
| 3.130 Legal Status From the Supply |
| 3.131 Manufacturing Activity Value Set |
| 3.132 Marketing Authorisation Application Legal Basis |
| 3.133 Marketing Status |
| 3.134 Master File Identifier Type |
| 3.135 Master File Type |
| 3.136 Material |
| 3.137 Medical Dictionary For Regulatory Activities Code System |
| 3.138 Medicinal Product Name Part Type |
| 3.139 Medicinal Product Type |
| 3.140 Medicine Profile |
| 3.141 Packaging |
| 3.142 Paediatric Use Indicator |
| 3.143 Pharmaceutical Dose Form |
| 3.144 Product Category |
| 3.145 Product Cross Reference Type |
| 3.146 Promotion |
| 3.147 Quantity Operator |
| 3.148 Reason for Marketing Unavailability |
| 3.149 Record Status |
| 3.150 Regulatory Authorization Registration Procedure |
| 3.151 Regulatory Entitlement |
| 3.152 Regulatory Entitlement Status |
| 3.153 Routes and Methods Of Administration |
| 3.154 Shelf Life Type |
| 3.155 Special Precautions for Storage |
| 3.156 Substance Origin |
| 3.157 Supply |
| 3.158 Unit Of Measurement Value Set |
| 3.159 Units Of Presentation |
| 3.160 XEVMPD Medicinal Product Type |
| 3.161 1. Get Product Bundle |
| 3.162 2. Change pack size |
| 3.163 3. Change pack size (response) |
| 3.164 4. Add manufacturing operation |
| 3.165 5. Add manufacturing operation (response) |
| 3.166 ActivityDefinition |
| 3.167 DocumentReference |
| 3.168 DocumentReference |
| 3.169 Organization |
 3.170 PractitionerRole |